肝动脉化疗栓塞术治疗肝癌的临床应用价值
1资料与方法,2结果,3讨论,参考文献
【摘要】 目的 探讨肝动脉化疗栓塞术(TACE)治疗肝癌的临床疗效及应用价值。方法 对208例肝癌患者先进行数字减影血管造影(DSA),然后行TACE。对患者术前、术后肿瘤的大小及症状体征进行比较,随访1、2、3年及以上生存期。结果 208例肝癌中肿瘤体积缩小141例(68%),肿瘤血管减少191例(92%),AFP值下降者137例(66%),恢复正常者70例(34%)。其中巨块型113例,结节型51例,弥漫型16例,转移性肝癌28例。TACE介入治疗后患者症状与体征均有明显好转和改善,无严重并发症发生。1、2、3年生存期分别为82.2%、52.4%、47.5%,3年以上者仍在随访中。结论 TACE具有微创、安全、高效的优点,可明显提高患者的生命质量和延长生存期,是目前肝癌治疗的首选方法,具有重要的临床应用价值。Yang Sifu,Ni Fangli,Huang Pingbo,et al.
Department of Radiology,Zhongyuan Oilfield General Hospital,Puyang,Henan457001.
【Abstract】 Objective To study the value and curative effect of TACE on hepatocellular carcinoma.Methods 208sufferers who performed a DSA,then proceed the TACE.To comparison the size and symptoms before and after operation,and to visit their period of exist years.Results 141persons whose tumor’s size is contract,and191tumor blood vessel reduced;137persons descent their AFP,and70recovered normal;113persons are belong to huge type,51are nodular type,16are widespread type,28are transfer type.The person who cured by TACE have no serious compliˉcations occurrence and get the symptoms and ameliorative or turn for better.The existence of1 ......
您现在查看是摘要页,全文长 9210 字符。